SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003080
Filing Date
2021-11-04
Accepted
2021-11-04 16:21:27
Documents
92
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-20210930.htm   iXBRL 10-Q 4907975
2 EX-10.1 bbio-ex10_1.htm EX-10.1 74244
3 EX-31.1 bbio-ex31_1.htm EX-31.1 30828
4 EX-31.2 bbio-ex31_2.htm EX-31.2 30946
5 EX-32.1 bbio-ex32_1.htm EX-32.1 14406
6 EX-32.2 bbio-ex32_2.htm EX-32.2 14696
  Complete submission text file 0000950170-21-003080.txt   17692445

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbio-20210930_lab.xml EX-101.LAB 767306
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbio-20210930_cal.xml EX-101.CAL 83021
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbio-20210930_def.xml EX-101.DEF 426142
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbio-20210930_pre.xml EX-101.PRE 599868
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbio-20210930.xsd EX-101.SCH 107797
12 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20210930_htm.xml XML 3840354
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 211380339
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences